Litcius/Paper detail

TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages

Ana Henriques, Maria Salvany-Celades, Paula Nieto, Sergio Palomo‐Ponce, Marta Sevillano, Xavier Hernando‐Momblona, Emily Middendorp-Guerra, Montserrat Llanses Martinez, Esther Haak, Juan C. Nieto, Ginevra Caratù, Doménica Marchese, Mireia Gil-Raga, Sébastien Tosi, Theresa Suckert, Jordi Badia-Ramentol, Adrià Caballé, Carolina Sánchez, Lídia Mateo, Daniele V. F. Tauriello, Antoni Riéra, Elena Sancho, Camille Stephan‐Otto Attolini, Alejandro Prados, Holger Heyn, Eduard Batlle

2025Nature Genetics20 citationsDOIOpen Access PDF

Topics & Concepts

BiologyImmune systemTumor microenvironmentCancer researchColorectal cancerImmunotherapyImmunologyBlockadeT cellInnate immune systemImmune checkpointCancer immunotherapyAcquired immune systemCancerExtracellular matrixImmunityImmune toleranceMacrophageDiseaseCancer cellCellSignal transductionCell signalingImmune cells in cancerTGF-β signaling in diseasesCancer Immunotherapy and Biomarkers
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages | Litcius